These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transforming activity of a newly cloned androgen-induced growth factor. Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T, Sato B. Oncogene; 1994 Feb; 9(2):455-62. PubMed ID: 8290257 [Abstract] [Full Text] [Related]
29. Growth factors regulating normal and malignant melanocytes. Halaban R. Cancer Treat Res; 1991 Mar 17; 54():19-40. PubMed ID: 1673857 [No Abstract] [Full Text] [Related]
30. Suppression of carcinogenesis by retinoids: interactions with peptide growth factors and their receptors as a key mechanism. Sporn MB, Roberts AB. Princess Takamatsu Symp; 1985 Mar 17; 16():149-58. PubMed ID: 3916193 [Abstract] [Full Text] [Related]
31. [Transforming growth factor-beta and malignant growth]. Keski-Oja J, Alitalo K. Duodecim; 1986 Mar 17; 102(15):1015-23. PubMed ID: 3463502 [No Abstract] [Full Text] [Related]
32. Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Ibbotson KJ, D'Souza SM, Ng KW, Osborne CK, Niall M, Martin TJ, Mundy GR. Science; 1983 Sep 23; 221(4617):1292-4. PubMed ID: 6577602 [Abstract] [Full Text] [Related]